Abdullah A. Elgazar

Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, <i>in vitro</i> and <i>in silico</i> studies

Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

Isolates from <scp><i>Alpinia officinarum</i></scp> Hance attenuate LPS‐induced inflammation in HepG2: Evidence from <i>in silico</i> and <i>in vitro</i> studies

Abdullah A. Elgazar, Nabil M. Selim, Nabil Mohie Abdel‐Hamid et al. · Phytotherapy Research · 2018 · 67 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation

Mohamed A. Said, Wagdy M. Eldehna, Alessio Nocentini et al. · European Journal of Medicinal Chemistry · 2020 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Chrysophanol, Physcion, Hesperidin and Curcumin Modulate the Gene Expression of Pro-Inflammatory Mediators Induced by LPS in HepG2: In Silico and Molecular Studies

Nabil M. Selim, Abdullah A. Elgazar, Nabil Mohie Abdel‐Hamid et al. · Antioxidants · 2019 · 65 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and <i>in silico</i> study

Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14